Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies
Frontiers in Cellular and Infection Microbiology · 08.05.2025 · 15
DOI: 10.3389/fcimb.2025.1567592 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 08.05.2025. Verfasst von Zewei Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Henan University, Kaifeng, China. Hauptthemen laut MEDLINE: Biomarkers, Tuberculosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tuberculosis (TB) remains a global health challenge, with timely and accurate diagnosis being critical for effective disease management and control. Recent advancements in the field of TB diagnostics have focused on the identification and utilization of blood-based biomarkers, offering a non-invasive, rapid, and scalable approach to disease detection. This review provides a comprehensive overview of the latest progress in blood-based biomarkers for TB, highlighting their potential to revolutionize diagnostic strategies. Furthermore, we explore emerging technologies such as NGS, PET-CT, Xpert and line probe assays, which have enhanced the sensitivity, specificity, and accessibility of biomarker-based diagnostics. The integration of artificial intelligence (AI) and machine learning (ML) in biomarker analysis is also examined, showcasing its potential to improve diagnostic accuracy and predictive capabilities. This review underscores the need for multidisciplinary collaboration and continued innovation to translate these promising technologies into practical, point-of-care solutions. By addressing these challenges, blood-based biomarkers and emerging technologies hold the potential to significantly improve TB diagnosis, ultimately contributing to global efforts to eradicate this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Henan University, Kaifeng, China.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
- School of Nursing and Health, Henan University, Kaifeng, China.
- Institute of Cell Biology, Zhejiang University, Hangzhou, China.
Zitieren
APA
Yang, Z., Li, J., Shen, J., Cao, H., Wang, Y., Hu, S., Du, Y., Wang, Y., Yan, Z., Xie, L., Li, Q., Gomaa, S. E., Liu, S., Li, X., & Li, J. (2025). Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1567592
Vancouver
Yang Z, Li J, Shen J, Cao H, Wang Y, Hu S, et al. Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1567592
BibTeX
@article{Yang2025,
author = {Yang, Zewei and Li, Jingjing and Shen, Jiawen and Cao, Huiru and Wang, Yuhan and Hu, Sensen and Du, Yulu and Wang, Yange and Yan, Zhongyi and Xie, Longxiang and Li, Qiming and Gomaa, Salwa E and Liu, Shejuan and Li, Xianghui and Li, Jicheng},
title = {Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1567592}
}
EUVIMED